NTRS Financial Statements & Analysis
Complete financial statements for NTRS including income statement, balance sheet, and cash flow statement. Analyze NTRS's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
37
Concerning
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
31.0% ↑
Net Income
83.4% ↑
Gross Margin
-6.2% ↓
Operating Margin
38.6% ↑
Balance Sheet
Current Ratio
-16.7% ↓
Debt to Equity
-13.7% ↑
Asset Turnover
27.0% ↑
Cash Flow
Operating Cash Flow
-118.5% ↓
Net Cash Flow
-183.2% ↓
Free Cash Flow
-163.2% ↓
Cash Flow to Debt
-119.9% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 12.12B | 15.88B | 31.0% | |
| Gross Profit | 6.75B | 8.29B | 22.9% | |
| Operating Income | 1.46B | 2.66B | 81.6% | |
| Net Income | 1.11B | 2.03B | 83.4% | |
| EPS | 5.09 | 9.8 | 92.5% | |
| EBITDA | 2.10B | 3.38B | 60.8% | |
| Gross Margin | 55.70% | 52.24% | 6.2% | |
| Operating Margin | 12.09% | 16.75% | 38.6% | |
| Net Income Margin | 9.14% | 12.79% | 40.0% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 15.88B | 12.12B | 7.75B | 6.49B | 6.30B |
| Gross Profit | 8.29B | 6.75B | 6.75B | 6.55B | 5.98B |
| Operating Income | 2.66B | 1.46B | 1.77B | 2.01B | 1.63B |
| Net Income | 2.03B | 1.11B | 1.34B | 1.55B | 1.21B |
| EPS | 9.8 | 5.09 | 6.16 | 7.16 | 5.48 |
| EBITDA | 3.38B | 2.10B | 2.32B | 2.53B | 2.13B |
| Gross Margin | 52.24% | 55.70% | 87.07% | 100.89% | 94.84% |
| Operating Margin | 16.75% | 12.09% | 22.79% | 30.98% | 25.83% |
| Net Income Margin | 12.79% | 9.14% | 17.23% | 23.82% | 19.19% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |